annual meeting program - American Society of Clinical Oncology

MONDAY
Monday, June 7, 2010
1:00 PM - 5:00 PM
GENERAL POSTER SESSION
Patient and Survivor Care
Location: S Hall A2
Tracks(s): Patient and Survivor Care
Brd. 39A Denosumab in the treatment of bone metastases from advanced cancer or
multiple myeloma (MM): Analyses from a phase III randomized trial.
(Abstract #9042)
S. Vadhan-Raj, D. H. Henry, R. von Moos, V. Hungria, F. Goldwasser,
G. Scagliotti, J. Wang, S. Jun, R. D. Dansey, H. Yeh
Brd. 39B Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts)
with advanced cancer (excluding breast and prostate) or multiple myeloma
(MM): Results from a randomized phase III clinical trial. (Abstract #9043)
R. von Moos, D. Patrick, L. Fallowfield, C. S. Cleeland, D. H. Henry, Y. Qian,
R. D. Dansey, K. Chung
Brd. 39F Contraception after breast cancer: Results of a survey among French
gynecologists. (Abstract #9044)
H. Hocini, A. Hamy, A. Gorins, D. Serfaty, H. Abuellellah, B. Tournant, F. Perret,
S. Bonfils, M. Espie, GERM
Brd. 39G Treatment with antidepressant and anti-anxiety medications after breast
cancer diagnosis in a large HMO. (Abstract #9045)
V. P. Quinn, C. C. Avila, J. E. Schottinger, A. H. Fisher, R. Haque
Brd. 39H Development of a functional assessment of chronic illness therapy
questionnaire to assess dermatology-related quality of life in patients treated
with EGFR inhibitors: FACT-EGFRI. (Abstract #9046)
L. I. Wagner, S. E. Rosenbaum, M. Gandhi, K. Webster, M. S. Aneja, D. Cella,
J. Brieva, M. E. Lacouture
Brd. 40A Influence of fatigue after breast cancer adjuvant therapy on health care
utilization and perceived needs. (Abstract #9047)
K. Webber, D. Goldstein, B. K. Bennett, F. M. Boyle, P. L. De Souza, N. Wilcken,
M. Friedlander, A. R. Lloyd
Brd. 40B Satisfaction with physician–patient discussions on fertility and sexual health
among young women with cancer. (Abstract #9048)
M. M. Scanlon, A. H. Blaes, M. A. Geller, N. S. Majhail, T. C. Haddad
Brd. 40F Utility of pre-chemotherapy echocardiographical assessment of cardiac
abnormalities. (Abstract #9049)
N. V. Karanth, A. Roy, M. Joseph, C. Depasquale, C. S. Karapetis, B. Koczwara
Brd. 40G Evaluation of pandemic H1N1(2009) influenza vaccine in adults with solid
tumor malignancies on active systemic treatment. (Abstract #9050)
J. D. McGee, A. M. Oza, L. M. Tinker, J. Gubbay, K. MacAlpine, L. Shi, D. Villa,
J. Kuruvilla, L. Wang, H. Mackay
Brd. 40H Patient-reported side effects from molecularly targeted therapies in renal cell
carcinoma (RCC). (Abstract #9051)
V. J. Seery, B. M. McGree, M. Lee, D. F. McDermott, D. C. Cho
Brd. 41A Impact of the change in service name from “palliative” to “supportive” care
on patient referral at a comprehensive cancer center. (Abstract #9052)
S. Dalal, S. L. Palla, R. Chacko, L. Nguyen, N. A. Fadul, Z. Li, E. Bruera
Brd. 41B Pathophysiological role of hormones and cytokines in cancer cachexia.
(Abstract #9053)
H. Park, H. Kim, J. Kwon, J. Yun, S. Lee, S. Bae, C. Kim, N. Lee, D. Hong
Brd. 41C The cancer survivor survey: Using Web-based technology to assess cancer
survivor challenges. (Abstract #9054)
E. M. Smith, K. Skalla, T. Onega, K. Anton, S. Gallagher, J. Rhoda, W. DiSalvo,
A. Dietrich
378